AMD's Re-Rating in May

When you get a really epic gap where you get re-rated let's take something extreme an FDA approval yeah 30 percent you don't budge because markets are very efficient in getting you to where you belong when it's big news. If you're along the stock you'd sell like strangles against a lot of stock or something so buying it here no I think you're probably getting a hundred okay that's that's really interesting one last question on this: You just spent what two three weeks in Europe meeting institutional clients these are investors who primarily obviously they have allocations European equities or global equities but they're focused on US equities as that is what you do right. How are you